Literature DB >> 2981283

Dissociation of [35S]t-butylbicyclophosphorothionate binding differentiates convulsant and depressant drugs that modulate GABAergic transmission.

G Maksay, M K Ticku.   

Abstract

The dissociation of [35S]t-butylbicyclophosphorothionate ([35S]TBPT) from binding sites on membranes from rat cerebral cortex, after addition of saturating concentrations of convulsant and depressant drugs, was studied. The addition of unlabeled TBPT, picrotoxinin, or pentamethylenetetrazol resulted in dissociation patterns that were monophasic and not distinguishable, suggesting that these convulsants bind competitively to the same (convulsant) sites. In contrast, gamma-aminobutyric acid (GABA) greatly facilitated [35S]TBPT dissociation by binding allosterically to the GABA recognition site of the receptor-ionophore complex. TBPT dissociation was similarly accelerated by the depressants etazolate, (+)-etomidate, and barbiturates. The convulsant and depressant S(+) and R(-) stereoisomers of N-methyl-5-phenyl-5-propyl-barbituric acid displayed large stereoselectivity in the acceleration of TBPT dissociation. These results suggest that depressants bind to sites different from the convulsant sites of the allosteric GABA receptor complex, or the binding of depressants to the same population of sites elicits negative cooperativity and dissociates the convulsants.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981283     DOI: 10.1111/j.1471-4159.1985.tb05439.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: GABA current blockade.

Authors:  D A Coulter; J R Huguenard; D A Prince
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

2.  Thermodynamics and kinetics of t-butylbicyclophosphorothionate binding differentiate convulsant and depressant barbiturate stereoisomers acting via GABAA ionophores.

Authors:  G Maksay; P Molnár; M Simonyi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

3.  Contrasting actions of a convulsant barbiturate and its anticonvulsant enantiomer on the α1 β3 γ2L GABAA receptor account for their in vivo effects.

Authors:  Rooma Desai; Pavel Y Savechenkov; Dorota Zolkowska; Ri Le Ge; Michael A Rogawski; Karol S Bruzik; Stuart A Forman; Douglas E Raines; Keith W Miller
Journal:  J Physiol       Date:  2015-11-15       Impact factor: 5.182

4.  The gamma-aminobutyrate/benzodiazepine receptor from pig brain. Enhancement of gamma-aminobutyrate-receptor binding by the anaesthetic propanidid.

Authors:  E F Kirkness; A J Turner
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

5.  The effects of drugs acting at the GABAA-receptor/ionophore after chemical kindling with the benzodiazepine receptor ligand FG 7142.

Authors:  H J Little; D J Nutt; S C Taylor
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

6.  Changes in benzodiazepine/GABA receptor complex function in benzodiazepine-tolerant mice.

Authors:  D J Nutt; S C Taylor; H J Little; B L Standing; R G Gale
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 7.  Ethanol and the benzodiazepine-GABA receptor-ionophore complex.

Authors:  M K Ticku
Journal:  Experientia       Date:  1989-05-15

8.  Interaction of picrotoxin with GABAA receptor channel-lining residues probed in cysteine mutants.

Authors:  M Xu; D F Covey; M H Akabas
Journal:  Biophys J       Date:  1995-11       Impact factor: 4.033

9.  Analysis of γ-aminobutyric acid (GABA) type A receptor subtypes using isosteric and allosteric ligands.

Authors:  Richard W Olsen
Journal:  Neurochem Res       Date:  2014-07-12       Impact factor: 3.996

10.  A unique amino acid of the Drosophila GABA receptor with influence on drug sensitivity by two mechanisms.

Authors:  H G Zhang; R H ffrench-Constant; M B Jackson
Journal:  J Physiol       Date:  1994-08-15       Impact factor: 5.182

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.